Syros Pharmaceuticals, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
Syros Pharmaceuticals' 10-K filing details its capital structure, outstanding warrants, and financial position, highlighting its focus on developing treatments for hematologic malignancies.